Condition
Chronic Inflammation
A mechanistic research topic often overstated in marketing.
Quick summary
- • No clear clinical endpoints yet
Overview
Chronic inflammation is a broad term spanning many conditions.
Mechanisms studied
Cytokine and immune-cell profiles are studied.
Human research
Human data remains limited.
Safety
Reported adverse events are mostly local — swelling, pain, or bruising at the harvest and injection sites. Infection and cell-processing quality remain the key risks to monitor.
Evidence limitations
Existing studies are limited by sample size, methodology, and follow-up, and SVF preparation differs substantially between centres, making cross-study comparison difficult.
Related research
- Level CClinical Trial
Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy)
First-in-human safety study: 18 patients with stage 3–5 CKDu received SVF via bilateral renal artery catheterization and were followed for 36 months.
- 2023
- Nicaragua / United States
- n = 18
- InsufficientClinical Trial
Efficacy and safety of autologous adipose tissue-derived stromal vascular fraction in patients with premature ovarian insufficiency: protocol for a single-centre randomised controlled trial
A pre-published randomized trial protocol testing SVF in premature ovarian insufficiency — no results yet.
- 2025
- China
Last updated: 2026-06-18 · arisa-w